Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Tampere University | OTHER |
| University of Helsinki | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of the study is to find out
Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and prognosis of refractory celiac disease.
Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Refractory dermatitis herpetiformis patients | Dermatitis herpetiformis rash not controlled by strict glute-free diet |
| |
| Dermatitis herpetiformis patients with good response to gluten-free diet | Dermatitis herpetiformis rash controlled by strict glute-free diet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment of prognosis of refractory dermatitis herpetiformis. No intervention | Other | Assessment of prognosis of refractory dermatitis herpetiformis. No intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| Clinical prognosis | Occurrence of complications | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Dietary adherence GIP test, CDAT, TG2, TG3 and Ema antibodies, anamnesis | The strictness of gluten-free diet (GIP test) | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Microbiata | skin, oral and intestinal microbiata | Baseline |
| Quality of life measure DLQI | DLQI (10-items, a higher score indicating lower quality of life) |
Inclusion Criteria:
Study patients:
Control patients:
Exclusion Criteria:
Study patients:
-Not following strict gluten-free diet
Control patients:
-Not following a strict gluten-free diet
Not provided
Not provided
Not provided
Adult patients with refractory dermatitis herpetiformis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kaisa Hervonen, PhD | Tampere University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tampere University Hospital | Tampere | 33101 | Finland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003874 | Dermatitis Herpetiformis |
| ID | Term |
|---|---|
| D003872 | Dermatitis |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D012872 | Skin Diseases, Vesiculobullous |
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline |
| Quality of life measure BGWP | PGWP (22-items with values 1-6, total score range 22-132, a higher score indicating better quality of life) | Baseline |
| Gastrointestinal symptoms GSRS | GSRS (15 items with values 1-7, total score 1-7 as a mean value of all scores, higher score indicating more severe symptoms) | Baseline |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |